ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,982Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 680

$1.19M Total Retail Price of All Prescriptions

Rank: 47 out of 680

575 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 575 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

30% of this provider’s 575 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

4% of this provider’s 19,816 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

45 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 1,334 865 S3 1 4
SIMVASTATIN 826 631 2 3
LISINOPRIL 820 628 3 5
OMEPRAZOLE 809 590 4 7
AMLODIPINE BESYLATE 797 705 5 1
LOSARTAN POTASSIUM 603 541 6 21
FUROSEMIDE 556 408 7 6
LEVOTHYROXINE SODIUM 550 490 8 2
ATENOLOL 514 420 9 19
CITALOPRAM HBR 510 393 10 22
POTASSIUM CHLORIDE 481 369 11 14
RANITIDINE HCL 432 318 12 56
ZOLPIDEM TARTRATE 430 282 13 17
CARVEDILOL 418 323 14 23
GABAPENTIN 391 268 15 15
TRAMADOL HCL 380 287 16 18
PRAVASTATIN SODIUM 372 280 17 10
NEXIUM 356 269 18 16
AMITRIPTYLINE HCL 308 204 R 19 47
METFORMIN HCL 273 209 20 8
MELOXICAM 271 243 21 24
CLOPIDOGREL 250 181 22 26
ALLOPURINOL 238 127 23 33
LABETALOL HCL 234 188 24 158
METOPROLOL SUCCINATE 226 178 25 13
LACTULOSE 224 178 26 92
JANUVIA 221 133 27 60
DONEPEZIL HCL 214 201 28 27
CRESTOR 211 173 29 25
PLAVIX 209 170 30 39
WARFARIN SODIUM 207 156 31 20
DIGOXIN 206 188 32 58
ISOSORBIDE MONONITRATE ER 199 187 33 59
MECLIZINE HCL 194 173 34 103
ATORVASTATIN CALCIUM 193 158 35 11
METOCLOPRAMIDE HCL 187 157 36 118
AMLODIPINE BESYLATE-BENAZEPRIL 184 117 37 43
POLYETHYLENE GLYCOL 3350 177 158 38 62
DIOVAN 173 131 39 31
CARBIDOPA-LEVODOPA 164 125 40 117
PREDNISONE 162 118 41 50
METOPROLOL TARTRATE 161 128 42 12
CYMBALTA 155 136 43 46
BENAZEPRIL HCL 148 72 44 40
ADVAIR DISKUS 144 124 45 53
CLONIDINE HCL 140 99 46 36
FLUOXETINE HCL 139 63 47 74
CEPHALEXIN 136 83 48 149
GUANFACINE HCL 133 87 R 49 281
TRIAMTERENE-HCTZ 132 124 50 52
TRAZODONE HCL 123 86 51 48
PROMETHAZINE HCL 121 67 R 52 96
LANTUS 119 93 53 49
SPIRONOLACTONE 115 64 54 82
NORTRIPTYLINE HCL 113 82 55 283
HYDROCHLOROTHIAZIDE 111 88 56 9
PRENATAL PLUS 111 94 56 274
NAMENDA 109 105 58 35
SERTRALINE HCL 106 90 59 28
AZITHROMYCIN 101 64 60 42
IBUPROFEN 100 41 61 126
SYNTHROID 99 89 62 38
CYCLOBENZAPRINE HCL 99 44 R 62 81
GLIPIZIDE 99 74 62 63
PREMARIN 98 92 R 65 105
ZETIA 96 92 66 87
TAMSULOSIN HCL 94 83 67 34
MIRTAZAPINE 93 80 68 78
GLYBURIDE-METFORMIN HCL 93 60 R 68 107
CIPROFLOXACIN HCL 92 80 70 57
NIFEDIPINE ER 91 83 71 75
GLIMEPIRIDE 89 85 72 29
ACETAMINOPHEN-CODEINE 87 67 S3 73 175
GLIPIZIDE XL 86 84 74 142
JANUMET 84 28 75 194
MUPIROCIN 82 57 76 130
CARISOPRODOL 82 16 R 76 83
VENLAFAXINE HCL ER 82 51 76 101
SULFAMETHOXAZOLE-TRIMETHOPRIM 81 47 79 94
LYRICA 79 57 80 77
SUCRALFATE 77 67 81 160
LEVOFLOXACIN 75 50 82 97
CLOTRIMAZOLE-BETAMETHASONE 71 59 83 138
QUETIAPINE FUMARATE 71 39 83 64
DOXAZOSIN MESYLATE 71 68 83 73
COMBIVENT 70 57 86 168
SPIRIVA 67 58 87 70
VERAPAMIL ER 66 56 88 100
LANTUS SOLOSTAR 66 22 88 84
AMIODARONE HCL 65 53 90 158
PROAIR HFA 65 39 90 67
FLUTICASONE PROPIONATE 63 45 92 41
FELODIPINE ER 63 52 92 146
ESCITALOPRAM OXALATE 63 53 92 45
KLOR-CON M20 63 60 92 61
HYDRALAZINE HCL 61 59 96 71
PHENYTOIN SODIUM EXTENDED 61 26 96 115
METFORMIN HCL ER 59 39 98 54
ALENDRONATE SODIUM 57 52 99 32
FLUCONAZOLE 57 31 99 139
DOXEPIN HCL 57 29 99 200
ENALAPRIL MALEATE 54 35 102 65
NABUMETONE 54 36 102 174
DILTIAZEM 24HR ER 53 51 104 132
DIOVAN HCT 53 36 104 55
LOVASTATIN 53 49 104 44
SINGULAIR 52 42 107 91
ACTOS 52 38 107 114
ROPINIROLE HCL 51 49 109 99
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.